
WASHINGTON, Dec. 10 (Xinhua) -- U.S. researchers have found antibodies against COVID-19 in blood samples dating back to mid-December 2019, weeks before the country's first officially-confirmed infections of the disease.
In a study conducted by scientists from the U.S. Centers for Disease Control and Prevention (CDC), residual archived samples from 7,389 routine blood donations collected by the American Red Cross from Dec. 13, 2019 to Jan. 17, 2020, from donors resident in nine states were tested at the CDC for anti-coronavirus antibodies.
Of the 7,389 samples collected from the states of California, Connecticut, Iowa, Massachusetts, Michigan, Oregon, Rhode Island, Washington, and Wisconsin, 106 were reactive by pan-immunoglobulin. Further confirmation testing of 90 samples suggests the presence of anti-SARS-CoV-2-reactive antibodies.
Specimens collected on Dec. 13-16, 2019, and those collected between Dec. 30, 2019 to Jan. 17, 2020, were summarized separately.
The results of the research were published late last month on the Clinical Infectious Diseases journal.
Fire brigade in Shanghai holds group wedding
Tourists enjoy ice sculptures in Datan Town, north China
Sunset scenery of Dayan Pagoda in Xi'an
Tourists have fun at scenic spot in Nanlong Town, NW China
Harbin attracts tourists by making best use of ice in winter
In pics: FIS Alpine Ski Women's World Cup Slalom
Black-necked cranes rest at reservoir in Lhunzhub County, Lhasa
China's FAST telescope will be available to foreign scientists in April
"She power" plays indispensable role in poverty alleviation
Top 10 world news events of People's Daily in 2020
Top 10 China news events of People's Daily in 2020
Top 10 media buzzwords of 2020
Year-ender:10 major tourism stories of 2020
No interference in Venezuelan issues
Biz prepares for trade spat
Broadcasting Continent
Australia wins Chinese CEOs as US loses